On April 30, 2026, the FDA proposed formally excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List - which would eliminate the remaining legal pathway for 503B outsourcing facilities to compound these medications in bulk
Bioactive compounds of tomato: Cancer chemopreventive effects and influence on the transcriptome in hepatocytes
All peptides offered are strictly for laboratory research use only and are not intended for human or veterinary use
These studies demonstrated beneficial increases in multiple immune functions, such as a significant increase in NK cell activity, cytokine response, and immune modulation.* The latest study is in the process of peer-review prior to publication
It depends on your symptoms, lab results, sleep quality, recovery needs, hormone markers, body composition goals, and medical history